AWM
HQL

AllSquare Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History

AllSquare Wealth Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,212
Closed -$43K – 405
2017
Q4 		$43K Buy
2,212
+89
+4% +$1.78K 0.03% 158
2017
Q3 		$46K Buy
+2,123
New +$45.1K 0.04% 147
2017
Q2 		– Sell
-2,084
Closed -$40K – 262
2017
Q1 		$40K Buy
2,084
+38
+2% +$704 0.04% 147
2016
Q4 		$35K Buy
2,046
+1,046
+105% +$18.4K 0.03% 156
2016
Q3 		$19K Buy
+1,000
New +$18.8K 0.02% 175

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
CAN
Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

AllSquare Wealth Management's HQL Position: Q1 2018 in Review

AllSquare Wealth Management sold out of abrdn Life Sciences Investors (HQL) in Q1 2018, closing a stake of 2,212 shares — an estimated $43K sold.

AllSquare Wealth Management first reported a position in HQL in Q3 2016 and held it in 5 quarters. The position peaked at $46K in Q3 2017. 56 funds tracked by Wall St. Rank hold HQL as of Q1 2018.

  • AllSquare Wealth Management reported no remaining abrdn Life Sciences Investors position as of Q1 2018 after selling out during the quarter.
  • AllSquare Wealth Management sold 2,212 abrdn Life Sciences Investors shares in Q1 2018, an estimated $43K.
  • AllSquare Wealth Management first reported a position in abrdn Life Sciences Investors in Q3 2016 and held it in 5 quarters.
  • AllSquare Wealth Management's abrdn Life Sciences Investors position peaked at $46K in Q3 2017.
  • 56 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2018.

Based on AllSquare Wealth Management's 13F filing for Q1 2018, filed 11 May 2018.